Bartels Laura Kathleen sold $4.4M of ARM

Arm Holdings (ARM) stock fell 6.7% after the September CPI report showed higher-than-expected inflation, increasing the likelihood of a Fed rate hike. The company's stock is sensitive to interest rates due to its reliance on future earnings from its AGI CPU.

A jury found Arm breached its license agreement with Qualcomm, awarding Qualcomm $2. Qualcomm accused Arm of failing to provide software tools and interfering with a chip deal. Arm maintained it acted in good faith. The verdict is part of an ongoing legal dispute between the two companies.

Arm Holdings (ARM) expressed satisfaction with a jury ruling that upheld its licensing agreements against Qualcomm, awarding minimal damages. The company's GF Value™ suggests it is modestly overvalued by 29.4%, with a GF Score™ of 70. Insider activity shows no recent buying, while gurus hold balanced positions. Arm's P/E ratio is 260.86x, above its 5-year median.

A Delaware jury ruled in a lawsuit between Qualcomm (QCOM) and Arm Holdings (ARM), finding ARM breached its license agreement with QCOM but also ruling in ARM's favor on four claims. QCOM's stock rose nearly 2%, while ARM's fell 0.3%. The case involved disputes over software tools, pricing, and commercial negotiations. ARM's stock has gained 135% YTD, while QCOM's has risen about 2%.

Qualcomm won a federal court case against Arm Holdings, with a jury ruling that Arm breached their license agreement and interfered with Qualcomm's business. The trial lasted five days, and Qualcomm was awarded $2 in nominal damages. Qualcomm accused Arm of disrupting a $170 million chip sale to Meta and violating pricing structures. Arm had previously withdrawn its appeal in a related case.

Qualcomm won a jury ruling against Arm, claiming Arm violated their licensing agreement. Arm's stock fell 1% post-verdict. Arm is valued at $255.06, 29.8% above GF Value™ of $196.51, with a GF Score™ of 70/100. Analysts note high P/E ratio and insider selling as cautionary signs for investors.